BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19089979)

  • 1. Intrinsic structural disorder of mouse proNGF.
    Paoletti F; Covaceuszach S; Konarev PV; Gonfloni S; Malerba F; Schwarz E; Svergun DI; Cattaneo A; Lamba D
    Proteins; 2009 Jun; 75(4):990-1009. PubMed ID: 19089979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP binding to Nerve Growth Factor (NGF) and pro-Nerve Growth Factor (proNGF): an endogenous molecular switch modulating neurotrophins activity.
    Paoletti F
    Biochem Soc Trans; 2024 May; ():. PubMed ID: 38716884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of nerve growth factor in complex with lysophosphatidylinositol.
    Sun HL; Jiang T
    Acta Crystallogr F Struct Biol Commun; 2015 Jul; 71(Pt 7):906-12. PubMed ID: 26144237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression system affects the binding affinity between p75NTR and proNGF.
    Hino M; Nakanishi M; Nomoto H
    Biochem Biophys Rep; 2024 Jul; 38():101702. PubMed ID: 38596407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct conformational changes occur within the intrinsically unstructured pro-domain of pro-Nerve Growth Factor in the presence of ATP and Mg
    Paoletti F; Covaceuszach S; Cassetta A; Calabrese AN; Novak U; Konarev P; Grdadolnik J; Lamba D; Golič Grdadolnik S
    Protein Sci; 2023 Feb; 32(2):e4563. PubMed ID: 36605018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophic Activity and Its Modulation by Zinc Ion of a Dimeric Peptide Mimicking the Brain-Derived Neurotrophic Factor N-Terminal Region.
    Russo L; Giacomelli C; Fortino M; Marzo T; Ferri G; Calvello M; Viegi A; Magrì A; Pratesi A; Pietropaolo A; Cardarelli F; Martini C; Rizzarelli E; Marchetti L; La Mendola D; Trincavelli ML
    ACS Chem Neurosci; 2022 Dec; 13(23):3453-3463. PubMed ID: 36346920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untangling the Conformational Plasticity of V66M Human proBDNF Polymorphism as a Modifier of Psychiatric Disorder Susceptibility.
    Covaceuszach S; Peche LY; Konarev PV; Grdadolnik J; Cattaneo A; Lamba D
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Cation-Chloride Co-Transporter NKCC1 to Re-Establish GABAergic Inhibition and an Appropriate Excitatory/Inhibitory Balance in Selective Neuronal Circuits: A Novel Approach for the Treatment of Alzheimer's Disease.
    Capsoni S; Arisi I; Malerba F; D'Onofrio M; Cattaneo A; Cherubini E
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why Are We Scientists? Drawing Inspiration From Rita Levi-Montalcini.
    Malerba F
    Front Cell Neurosci; 2021; 15():741984. PubMed ID: 35126056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Endogenous Ligands Modulation of Nerve Growth Factor Bioactivity: A Structural Biology Overview.
    Paoletti F; Lamba D
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous modulators of neurotrophin signaling: Landscape of the transient ATP-NGF interactions.
    Paoletti F; Merzel F; Cassetta A; Ogris I; Covaceuszach S; Grdadolnik J; Lamba D; Golič Grdadolnik S
    Comput Struct Biotechnol J; 2021; 19():2938-2949. PubMed ID: 34136093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined evolutionary and structural approach to disclose the primary structural determinants essential for proneurotrophins biological functions.
    Covaceuszach S; Peche LY; Konarev PV; Lamba D
    Comput Struct Biotechnol J; 2021; 19():2891-2904. PubMed ID: 34094000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels.
    Brandi R; Fabiano M; Giorgi C; Arisi I; La Regina F; Malerba F; Turturro S; Storti AE; Ricevuti F; Amadio S; Volontè C; Capsoni S; Scardigli R; D'Onofrio M; Cattaneo A
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into SorCS2-Nerve Growth Factor complex formation.
    Leloup N; Chataigner LMP; Janssen BJC
    Nat Commun; 2018 Jul; 9(1):2979. PubMed ID: 30061605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve Growth Factor: Early Studies and Recent Clinical Trials.
    Rocco ML; Soligo M; Manni L; Aloe L
    Curr Neuropharmacol; 2018; 16(10):1455-1465. PubMed ID: 29651949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational characterization of nerve growth factor-β reveals that its regulatory pro-part domain stabilizes three loop regions in its mature part.
    Trabjerg E; Kartberg F; Christensen S; Rand KD
    J Biol Chem; 2017 Oct; 292(40):16665-16676. PubMed ID: 28798232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Optimized Procedure for the Site-Directed Labeling of NGF and proNGF for Imaging Purposes.
    Di Matteo P; Calvello M; Luin S; Marchetti L; Cattaneo A
    Front Mol Biosci; 2017; 4():4. PubMed ID: 28210618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor.
    Paoletti F; de Chiara C; Kelly G; Covaceuszach S; Malerba F; Yan R; Lamba D; Cattaneo A; Pastore A
    Front Mol Biosci; 2016; 3():83. PubMed ID: 28083536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and regulation of neurotrophin synthesis and secretion.
    Al-Qudah MA; Al-Dwairi A
    Neurosciences (Riyadh); 2016 Oct; 21(4):306-313. PubMed ID: 27744458
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.